20th Biosimilars Congregation 2025

20th Biosimilars Congregation 2025

“Where Biosimilar leaders meet Innovation Strategy & Success”

11th December 2025 Kohinoor Continental Hotel Mumbai India

This year we place a strong focus on the evolving dynamics of biologics market competition with an emphasis on building a sustainable and competitive framework for biosimilars. Key themes include pricing strategies procurement practices and regional efforts to ensure long-term sustainability and accessibility. We’ll explore the critical factors influencing biosimilar uptake—and what lies beyond it. Global policymakers and industry leaders will share actionable insights and collaborative strategies to foster access affordability and innovation in biological treatments. The high-level conference sessions are designed to equip you with the latest business models regulatory updates and market strategies. You’ll gain invaluable opportunities to benchmark your approach against industry frontrunners and develop immediate action plans in response to challenges like R&D costs regulatory barriers and market entry hurdles—all against the backdrop of rising commercial potential. 

It is our great pleasure to welcome you to this influential platform. We hope that the insights shared and connections made here will benefit not only your organization but the broader healthcare ecosystem. We wish and pray that you have a rewarding & impactful experience at our 20th Biosimilars Congregation 2025.

Sponsor / Delegate Registration E-mail - a2F2aXRoYSB8IHZpcnR1ZWluc2lnaHQgISBjbyAhIGlu or M: +91 9361957193

SPONSORSHIP:

Exhibitor – Medclinica

Conference Sponsor & Exhibition Stall – Should you wish to Sponsor or purchase a Exhibition Stall (Booth) or a paid Speaker Slot you can simply email your interest and queries.

DELEGATE REGISTRATION:

Super Early Bird Price (Valid until 31 Oct 2025) –11000 + GST 18% per delegate

Early Bird Price (Valid until 1st Nov – 28th Nov) –14000 + GST 18% per delegate

Standard Price (Valid from 29 Nov 2025) - INR 16000 + GST 18% per delegate.

KEY SPEAKERS:

DEBASHIS SARKAR Senior VP & Head Emerging MarketsAurobindo

SANJEEV GUPTA Sr. Vice President & Head Biosimilar Ipca Laboratories

SUMITA MOHAPATRO PANI Sr. VP & Head - Business Development & Inlicensing Business Ethics & ComplianceLupin

HANMANT BARKATE Group VP & Global Head - Medical Affairs Glenmark

ABHISHEK SINHA VP Global Regulatory AffairsAdvanz Pharma

MANNAN KHAMBATI VP Biotech Manufacturing Bharat Serums and Vaccines

VIKAS VAISHNAVI Director Program Patient Safety Sandoz

SONALI KHANRA Associate Director RWE Novartis

MILIND ANTANI Leader Pharma & HealthcareNishith Desai Associates

AMARNATH SUGUMARAN Associate Director & Cluster Head Medical Affairs Cipla

SANTOSH TAUR Director Medical Affairs Vaccines Rare Diseases & Digital Pfizer 

AMARNATH CHATTERJEE Director & Head Analytical Sciences & QCCipla

SOURABH FULMALI Global Medical DirectorGSK

RAVI SAILAPPAN Head – EPD Quality Systems  Abbott

SANJAY B NIRANJAN Assistant Director Bioassay Development (Biosimilars)Lupin

SHUVANKAR BALLAV Head Regulatory Affairs - Advanced Biotech Lab (ABL) Ipca Laboratories 

SAMIR KULKARNI Head - DBT ICT Center Institute of Chemical Technology

AKSHAYA ODAK Head - Regulatory Affairs (Biotech) Lupin

SWEETY MATTHEW Regulatory Professional- Global Regulatory Affairs: CMC Rare DiseasesNovo Nordisk

SEEMA BHANDARKAR Commercial Head CIS & Russia Biosimilars Biocon

APARNA PRABHUNE Deputy GM – Regulatory AffairsWockhardt

MAYUR MAYBHATE Head Medical Affairs Alkem Laboratories

KAVITA LAMROR Partner RWE & Digital TransformationMaxis Clinical Sciences

KHOKAN DEBNATH Sr GM / (Head) – Regulatory Affairs Clinical Operations PV QA & Compliance (India & Emerging Market) Wockhardt 

KHUSHBOO PANCHAL Business Strategy Manager - Asia Pacific RegionMSD

VISHWAS SOVANI Founder Director Pharmawisdom

Plus more joining soon

KEY THEMES:

Regulatory Updates & Policy Shifts

Market Access Pricing & Affordability Strategies

Cost Competitiveness vs. Global Players

Scaling Manufacturing / Development / Commercialisation

Export Growth & Global Market Alignment

Next-Gen Biosimilars & Technological Innovation

Role & Expectations of Payers

Patent Landscape & IP Navigation in India

Real-World Evidence (RWE) & PMS in India

Patient Awareness & Education Initiatives

Physician Trust & Clinical Confidence Building

Quality Standards & Biosimilar Pharmacovigilance

Digital Tools in Biosimilar R&D and Process Monitoring

What’s the way forward? / Opportunity - Learn & Network

WHO SHOULD ATTEND AND WHO YOU’LL MEET:

CSOs CMOs Vice Presidents Presidents Heads Directors Team Leaders and Senior Scientists from the following roles;

Biopharmaceuticals/ Biotherapeutics Follow on Biologics/Follow on Proteins Biologics/Biotechnology/ Bio generics Legal Affairs Intellectual Property Health Economics Pricing and Reimbursement Clinical Immunology Principal Scientist Chief Scientific Officer Process Control and Analytical Technologies Analytical Characterisation Regulatory Quality Affairs/ Quality Control New Product Development Process Science Portfolio Management Research & Development Business Development Business Operations Scientific Affairs Commercial Affairs

Get more from this year’s event with a broader scope that unites the entire communications and biosimilars value chain. Take full advantage of our dedicated networking sessions and explore cutting-edge innovations at the co-located exhibition where leading international vendors showcase the products of tomorrow.

Also check out other Exhibitions in Mumbai, Business events in Mumbai, Nonprofit events in Mumbai.